发明申请
- 专利标题： Compounds for the Treatment of Hepatitis C
- 专利标题（中）： 用于治疗丙型肝炎的化合物
-
申请号： US12039239申请日： 2008-02-28
-
公开(公告)号： US20080227769A1公开(公告)日： 2008-09-18
- 发明人: Robert G. Gentles , Xiaofan Zheng , Min Ding , Yong Tu , Ying Han , Piyasena Hewawasam , John F. Kadow , John A. Bender , Kap-Sun Yeung , Katharine A. Grant-Young , Thomas W. Hudyma
- 申请人： Robert G. Gentles , Xiaofan Zheng , Min Ding , Yong Tu , Ying Han , Piyasena Hewawasam , John F. Kadow , John A. Bender , Kap-Sun Yeung , Katharine A. Grant-Young , Thomas W. Hudyma
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 主分类号： A61K31/397
- IPC分类号： A61K31/397 ; C07D223/14 ; A61P31/12 ; A61K31/55
摘要：
The invention encompasses compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
公开/授权文献
- US07547690B2 Compounds for the treatment of Hepatitis C 公开/授权日：2009-06-16